Horizon Investment Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,352
Closed -$3.1M 105
2017
Q1
$3.1M Sell
11,352
-397
-3% -$112K 1.39% 34
2016
Q4
$3.33M Sell
11,749
-553
-4% -$164K 1.58% 26
2016
Q3
$3.85M Buy
12,302
+765
+7% +$227K 1.95% 20
2016
Q2
$2.79M Buy
11,537
+1,694
+17% +$446K 1.41% 31
2016
Q1
$2.56M Buy
+9,843
New +$2.6M 1.17% 32
2015
Q3
Sell
-562
Closed -$227K 113
2015
Q2
$227K Sell
562
-50
-8% -$20.1K 0.09% 120
2015
Q1
$258K Buy
+612
New +$241K 0.11% 120

Other funds holding BIIB

Horizon Investment Services's BIIB Position: Q2 2017 in Review

Horizon Investment Services sold out of Biogen (BIIB) in Q2 2017, closing a stake of 11,352 shares — an estimated $3.1M sold.

Horizon Investment Services first reported a position in BIIB in Q1 2015 and held it in 7 quarters. The position peaked at $3.85M in Q3 2016. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Horizon Investment Services reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Horizon Investment Services sold 11,352 Biogen shares in Q2 2017, an estimated $3.1M.
  • Horizon Investment Services first reported a position in Biogen in Q1 2015 and held it in 7 quarters.
  • Horizon Investment Services's Biogen position peaked at $3.85M in Q3 2016.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Horizon Investment Services's 13F filing for Q2 2017, filed 14 Aug 2017.